摘要
为了解肺腺癌p16基因外显子2的突变情况,应用聚合酶链反应(PCR)及PCR双链DNA循环测序技术分析了22例肺腺癌中的p16基因,结果显示:22例肺腺癌中存在2例纯合缺失,3例点突变。其中病例1密码子56由CTG→CAG的突变,编码的氨基酸由亮氨酸变为谷氨酰胺;病例12密码子121由TAC→TGC的突变,编码的氨基酸由酪氨酸变为半胱氨酸;病例10密码子80由GAG→AAG的突变,编码的氨基酸由谷氨酸变为赖氨酸,同时这例密码子79存在一个由CGG→AGG的同义突变。另外还发现1例由单碱基缺失导致的移码突变。p16基因在22例肺腺癌中纯合缺失频率为9.1%,基因突变频率为27.3%。可见,多重肿瘤抑制基因p16与肺腺癌的发生发展密切相关并在其演进过程中起着一定的作用。
To probe into the relationship between tumorigenesis of primary lung adenocarcinoma and p16 gene changes,we analyzed 22 cases of primary lung adenocarcinoma for homozygous deletion and subtle mutations of p16 using PCR and direct dsDNA sequencing techniques.2 homozygous deletions,3 point mutations and 1 frame shift were detected.The mutations included 2 missense mutations and 1 silent mutation.Our observation showed that mutation of p16 gene was associated with the tumorigenesis and development of lung adenocarcinoma and might play a role in lung adenocarcinoma progression.
出处
《中华医学遗传学杂志》
CAS
CSCD
北大核心
1997年第3期152-154,共3页
Chinese Journal of Medical Genetics
关键词
肺癌
P16基因
基因突变
PCR
Lung adenocarcinoma p16 gene Gene mutation Polymerase chain reaction